ZY
Non verificato

ZYUS Life Sciences Corporation

Di cosa scriviamo

FarmaceuticaMaterie primeMedicina - VarieMedicina alternativaSalute
15/07/2025
Biotecnologia
Materie prime
Farmaceutica
Medicina alternativa
Oncologia
Salute
Medicina - Varie
Mercato del lavoro
ZYUS Life Sciences Strengthens Clinical Leadership with Appointment of Chief Medical Officer to Support Phase 2 Oncology Pain Trial
1.00
27/06/2025
Biotecnologia
Finanza
Salute
Associazioni/Professionisti
Farmaceutica
ZYUS Life Sciences Announces Closing of Unit Offering
1.00
17/06/2025
Salute
Materie prime
Scienza
Farmaceutica
Finanza
 ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering
1.00
22/05/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Medicina alternativa
Oncologia
Salute
Medicina - Varie
ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
1.00
16/05/2025
Mercato azionario
Salute
Materie prime
Scienza
Farmaceutica
ZYUS Life Sciences Announces Closing of Unit Offering
1.00
11/04/2025
Mercato azionario
Biotecnologia
Farmaceutica
Salute
ZYUS Life Sciences Corporation Announces Issuance of Bonus Warrants Pursuant to Loan Agreements
1.00
17/03/2025
Mercato del lavoro
Industria
Materie prime
Salute
Farmaceutica
Medicina - Varie
ZYUS Life Sciences Corporation Announces Assumption and Amendment of Promissory Note
1.00
23/12/2024
Scienza
Sanità
Medicina alternativa
Salute
Farmaceutica
Materie prime
ZYUS Life Sciences Corporation Announces Closing of Unsecured Loan and Amendment of Existing Shareholder Promissory Note
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0